par Praga, Claudio;Bergh, Jonas;Bliss, Judith M;Bonneterre, J;Cesana, Bruno;Coombes, Raoul Charles;Fargeot, Pierre;Folin, Annika;Fumoleau, Pierre;Giuliani, Rosa;Kerbrat, Pierre;Hery, Michel;Nilsson, Jonas;Onida, Francesco;Piccart-Gebhart, Martine
;Shepherd, L;Therasse, P.;Wils, Jaques;Rogers, David
Référence Journal of clinical oncology, 23, 18, page (4179-4191)
Publication Publié, 2005-06
;Shepherd, L;Therasse, P.;Wils, Jaques;Rogers, DavidRéférence Journal of clinical oncology, 23, 18, page (4179-4191)
Publication Publié, 2005-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Praga, Claudio; Bergh, Jonas; Bliss, Judith M; Bonneterre, J; Cesana, Bruno; Coombes, Raoul Charles; Fargeot, Pierre; Folin, Annika; Fumoleau, Pierre; Giuliani, Rosa; Kerbrat, Pierre; Hery, Michel; Nilsson, Jonas; Onida, Francesco; Piccart-Gebhart, Martine; Shepherd, L; Therasse, P.; Wils, Jaques; Rogers, David |
| Informations sur la publication: | Journal of clinical oncology, 23, 18, page (4179-4191) |
| Statut de publication: | Publié, 2005-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Breast Neoplasms -- drug therapy | |
| Chemotherapy, Adjuvant -- adverse effects | |
| Cyclophosphamide -- adverse effects | |
| Cyclophosphamide -- therapeutic use | |
| Data Interpretation, Statistical | |
| Epirubicin -- adverse effects | |
| Epirubicin -- therapeutic use | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Leukemia, Myeloid, Acute -- chemically induced | |
| Middle Aged | |
| Myelodysplastic Syndromes -- chemically induced | |
| Randomized Controlled Trials as Topic | |
| Risk Factors | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2005.05.029 | |
| info:pii/23/18/4179 | |
| info:pmid/15961765 |



